Novo goes after pharmacies compounding semaglutide

Compounding pharmacist
Danish pharma giant declares some compounded versions up to one-third impure The manufacturer of diabetes and weight-loss drugs Ozempic and Wegovy has taken legal action against two compounding pharmacies, accusing their products of being less potent than advertised and of containing impurities. The legal action by Novo Nordisk was instigated in Florida against compounders Wells

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Fewer Aussies visiting pharmacies: NAB
Next NZ hit by near total e-script outage